Physician profile
Alex A Huang
NPI 1821246141
$78,784.02
in general payments reported to CMS, 2019-2025
16 companies · $925 in 2025
The $925 reported for 2025 was more than what 75% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $6,066 · 2021: $11K · 2022: $23K · 2023: $2,373 · 2024: $18K · 2025: $925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $4,294 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,000.00 |
| Food and Beverage | $4,293.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Topcon Healthcare, INC. | $39,624.87 | 2021-2025 | |
| Glaukos Corporation | $9,117.18 | 2019-2025 | Idosetr, Idose, Istent Infinite |
| Heidelberg Engineering, INC. | $6,374.15 | 2019-2024 | Spectralis |
| Allergan, INC. | $5,762.17 | 2019-2022 | |
| Abbvie INC. | $5,333.07 | 2021-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $4,000.00 | 2019 | |
| W. L. Gore & Associates, INC. | $3,720.00 | 2020 | |
| Alcon Vision LLC | $2,382.51 | 2021-2025 | Hydrus Microstent, Centurion, Unity |
| Aerie Pharmaceuticals, INC. | $1,662.88 | 2019-2020 | |
| Sight Sciences, INC. | $415.75 | 2021-2025 | Omni Surgical System |
| Dexcom, INC. | $127.64 | 2024 | Dexcom G6 Transmitter |
| New World Medical,INC. | $81.70 | 2024-2025 | Streamline, Clearpath, Kahook Dual Blade |
| Dompe US, INC. | $66.35 | 2022 | |
| Nova Eye, INC. | $64.48 | 2025 | |
| Bausch & Lomb Americas INC. | $27.24 | 2024 | Xiidra, Miebo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $24.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.